TYRA (NASDAQ: TYRA) sells common shares under Rule 144 in June 2026

Rhea-AI Filing Summary

NEXTECH VI ONCOLOGY SCSP reported sales of TYRA common stock under a Rule 144 notice. The excerpt lists four dispositions in June 2026 with specific trade dates, share quantities, and gross proceeds for each trade. The broker listed is Merrill Lynch.

Insights

Securities Counsel

Rule 144 notice documents multiple June 2026 dispositions with per‑trade proceeds listed.

The excerpt lists four sales by NEXTECH VI ONCOLOGY SCSP on 06/01/2026, 06/23/2026, 06/24/2026, and 06/25/2026, each with share counts and dollar proceeds. The sales are presented with a named broker, Merrill Lynch, and the filings reference common stock on Nasdaq.

Timing and dollar amounts are explicit in the excerpt; further legal or market implications depend on additional disclosures such as beneficial ownership, holding period, or any locks which are not included in the provided text.

Key Figures

Trade on 06/01/2026: 15,457 shares Trade on 06/23/2026: 17,098 shares Trade on 06/24/2026: 24,113 shares +2 more

5 metrics

Trade on 06/01/2026 15,457 shares proceeds $491,644.12

Trade on 06/23/2026 17,098 shares proceeds $530,258.87

Trade on 06/24/2026 24,113 shares proceeds $748,959.09

Trade on 06/25/2026 72,281 shares proceeds $2,251,632.44

Securities type Common stock listed on Nasdaq in excerpt

Key Terms

Rule 144, Private Placement, Merrill Lynch

3 terms

Rule 144 regulatory

"Filer Information | 144: Filer Information"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Private Placement financial

"Securities To Be Sold | Private Placement"

A private placement is a way for companies to raise money by selling securities directly to a small group of investors instead of through a public offering. This process is often quicker and less regulated, making it similar to offering a special, exclusive investment opportunity to select individuals or institutions. For investors, it can provide access to unique investment options that are not available on public markets.

Merrill Lynch financial

"Common | Merrill Lynch 555 California Street 18th Floor"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/26/2026 - 05:00 PM Accepted by SEC EDGAR 06/26/2026 - 04:59 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California Street 18th Floor San Francisco CA 94104	308379	9541246.26	53177990	06/26/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/17/2021	Private Placement	Issuer			308379	09/17/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
NEXTECH VI ONCOLOGY SCSP Bahnhofstrasse 18 Zurich V8 8001	Common	06/01/2026	15457	491644.12
NEXTECH VI ONCOLOGY SCSP Bahnhofstrasse 18 Zurich V8 8001	Common	06/23/2026	17098	530258.87
NEXTECH VI ONCOLOGY SCSP Bahnhofstrasse 18 Zurich V8 8001	Common	06/24/2026	24113	748959.09
NEXTECH VI ONCOLOGY SCSP Bahnhofstrasse 18 Zurich V8 8001	Common	06/25/2026	72281	2251632.44

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Rule 144 notice for TYRA (TYRA) show?

The notice shows four sales of common stock reported in June 2026. It lists trade dates, share counts (15,457; 17,098; 24,113; 72,281) and gross proceeds for each transaction.

Who is listed as the selling holder in these TYRA sales?

The selling holder is identified as NEXTECH VI ONCOLOGY SCSP. The excerpt shows that entity as the source of the four dispositions reported in June 2026.

Which broker handled the reported TYRA transactions?

The broker shown is Merrill Lynch at 555 California Street, San Francisco. The excerpt associates that broker with the reported common‑stock sales.

How much did each reported TYRA sale generate in proceeds?

The excerpt lists proceeds as $491,644.12, $530,258.87, $748,959.09, and $2,251,632.44 for the trades on June 1, 23, 24, and 25, 2026 respectively.